Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer

Immune checkpoint blockade is a compelling approach in tumor immunotherapy. Blocking inhibitory pathways in T cells has demonstrated clinical efficacy in different types of cancer and may hold potential to also stimulate innate immune responses. A novel emerging potential target for immune checkpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeller, Tobias, Münnich, Ira A., Windisch, Roland, Hilger, Patricia, Schewe, Denis M., Humpe, Andreas, Kellner, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533923/
https://www.ncbi.nlm.nih.gov/pubmed/37781391
http://dx.doi.org/10.3389/fimmu.2023.1240275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533923/
https://www.ncbi.nlm.nih.gov/pubmed/37781391
http://dx.doi.org/10.3389/fimmu.2023.1240275

Ejemplares similares